Varicella zoster virus vaccines: effective, but concerns linger.

@article{Liesegang2009VaricellaZV,
  title={Varicella zoster virus vaccines: effective, but concerns linger.},
  author={Thomas J. Liesegang},
  journal={Canadian journal of ophthalmology. Journal canadien d'ophtalmologie},
  year={2009},
  volume={44 4},
  pages={
          379-84
        }
}
Both varicella and herpes zoster (HZ) can cause severe disease in certain age groups. The cell-mediated immune (CMI) response to the varicella zoster virus (VZV) is critical in preventing a recurrence of VZV. The varicella vaccine has markedly decreased the morbidity and mortality associated with varicella, but concerns linger about the cost and frequency of vaccine administration and the long-term effects on both adult varicella and HZ epidemiology in the individual and in the population… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.
SHOWING 1-10 OF 15 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 62 REFERENCES

Vaccination to prevent herpes zoster in older adults.

  • John W. Gnann
  • Medicine
  • The journal of pain : official journal of the American Pain Society
  • 2008
VIEW 1 EXCERPT